KOLMAR BNH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,150 KRW | -0.33% |
|
-3.32% | -15.55% |
| Sales 2024 * | 643B 467M | Sales 2025 * | 673B 489M | Capitalization | 439B 319M |
|---|---|---|---|---|---|
| Net income 2024 * | 45B 32.72M | Net income 2025 * | 52B 37.8M | EV / Sales 2024 * | 0.73 x |
| Net Debt 2024 * | 31B 22.54M | Net Debt 2025 * | 17.5B 12.72M | EV / Sales 2025 * | 0.68 x |
| P/E ratio 2024 * |
9.93
x | P/E ratio 2025 * |
8.56
x | Employees | 495 |
| Yield 2024 * |
2.03% | Yield 2025 * |
2.03% | Free-Float | 39.44% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.33% | ||
| 1 week | -3.32% | ||
| Current month | +3.13% | ||
| 1 month | +1.95% | ||
| 3 months | -9.44% | ||
| 6 months | -5.90% | ||
| Current year | -15.55% |
1 week
15 120.00
15 870.00
1 month
14 400.0015 970.00
Current year
14 210.0018 320.00
1 year
14 210.0022 700.00
3 years
14 210.0055 800.00
5 years
14 210.0072 900.00
10 years
14 210.0072 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hwa-Young Jung
CEO | Chief Executive Officer | 59 | 13-01-01 |
Yeo-Won Yoon
CEO | Chief Executive Officer | 48 | 15-08-19 |
Kwang-Il Kim
AUD | Comptroller/Controller/Auditor | 60 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yeo-Won Yoon
CEO | Chief Executive Officer | 48 | 15-08-19 |
Byeong-Mook Kim
BRD | Director/Board Member | 63 | 17-03-23 |
Hwa-Young Jung
CEO | Chief Executive Officer | 59 | 13-01-01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 15,150 | -0.33% | 22,915 |
| 24-04-25 | 15,200 | -0.39% | 32,540 |
| 24-04-24 | 15,260 | -0.78% | 74,039 |
| 24-04-23 | 15,380 | -1.98% | 26,551 |
| 24-04-22 | 15,690 | +0.13% | 50,832 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
KolmarBNH Co., Ltd, formerly MIRAE ASSET NO.2 SPECIAL PURPOSE ACQUISITION COMPANY, is a Korea-based company principally engaged in manufacture and distribution of health functional foods, cosmetics and pharmaceuticals. The Company mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The Company also produces cosmetics using natural extracts, and other pharmaceuticals. The Company also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
Sector
Food Processing
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
15,150
KRW
Average target price
24,000
KRW
Spread / Average Target
+58.42%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.55% | 319M | |
| +8.20% | 7.78B | |
| +1.64% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
- Stock Market
- Equities
- A200130 Stock
